OriGene Technologies, Inc.
Left ProductsProducts divider ServicesServices divider technologyTechnology divider researchResearch divider TechsupportTechSupport divider AboutAbout Right
 
Home Antibody All anti-TNFSF9 antibodies

Anti-TNFSF9 Antibody EPR1172Y

div

Specifications Citations Related Products Product Documents
SKU Description Amount Price Availability*  
TA301163
  • Rabbit Monoclonal Antibody against TNFSF9 (Clone EPR1172Y)
  • Free Sample of Positive Control: HEK293T cell transient overexpression lysate (LC418412) , 20ug
100ul 325 In Stock
Add to Shopping Cart
WB(1)
spacer
Also for TNFSF9 (NM_003811)
cDNA Clone shRNA/siRNA Lysate Protein Antibody

OriGene Data

ImmunogenA synthetic peptide corresponding to residues near the N-terminus of human 4-1BBL was used as an immunogen.
Clone NameEPR1172Y IsotypeIgG
Species ReactivityHuman ConcentrationLot dependent; please refer to CoA along with shipment
Guaranteed Application *WB Suggested DilutionsWB: 1:500; IHC: 1: 100; ICC: 1: 100; IP: 1:40
BufferpH: 7.40
Preservative: 0.01% Sodium azide
Constituents: 50% Glycerol, 0.05% BSA
Purification Tissue culture supernatant
Note Does not react with Mouse, Rat

Reference Data

Target NameHomo sapiens tumor necrosis factor (ligand) superfamily, member 9 (TNFSF9)
Alternative Name4-1BB-L; CD137L
Database LinkNP_003802
Function4-1BB was originally described as a cDNA expressed by activated murine T cells and subsequently demonstrated to encode a member of the tumor necrosis factor receptor family of integral membrane proteins. Recently, a murine ligand for 4-1BB (mu4-1BB-L) was cloned and demonstrated to be a member of an emerging family of ligands with structural homology to tumor necrosis factor. Both monoclonal antibody to hu4-1BB and cells transfected with hu4-1BB-L induced a strong proliferative response in mitogen co-stimulated primary T cells. In contrast, ligation of 4-1BB on T cell clones enhanced activation-induced cell death when triggered by engagement of the TCR/CD3 complex. (1). To reject tumors, T cells must overcome poor tumor immunogenicity and an adverse tumor microenvironment. It has been shown that primary human T cells expressing CD80 and 4-1BBL vigorously respond to tumor cells lacking costimulatory ligands and provoke potent rejection of large, systemic tumors in immunodeficient mice (2).
Related Pathway
Cytokine-cytokine receptor interaction

* Shipping is in business days
* OriGene provides validated application data and protocol, with money back guarantee.

WB Image
Western blot - TNFSF9 antibody [EPR1172Y]; Anti-TNFSF9 antibody [EPR1172Y] at 1/2000 dilution + 293T cell lysate at 10 µg.Secondary.HRP conjugated Goat anti-rabbit at 1/2000 dilution.Predicted band size : 27 kDa.Observed band size : 25 kDa .

 

spacer
Inc 5000 Healthcare Company Copyright © 2014 OriGene Technologies, Inc. All Rights Reserved. Legal Notices.
9620 Medical Center Dr., Suite 200, Rockville, MD 20850 • 1.888.267.4436

Reproduction of any materials from this website is strictly forbidden without permission.

All Products by: Title | Price | Category | Popularity | Best Sellers Topselling Products by: Title | Price | Category | Popularity | Favorites
Popular Categories: Popularity | Our Choices | All-Round Favorites | Title Topselling Categories: Popularity | Our Choices | All-Round Favorites | Title